Boralex Inc. (TSX:BLX)

Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,046	2,950	3,461	4,113	3,559	4,845
Market Cap Growth	-5.57%	-14.76%	-15.84%	15.56%	-26.54%	105.61%
Enterprise Value	7,685	6,849	6,993	7,311	7,514	7,828
PE Ratio	-	81.96	44.37	137.09	209.34	88.08
PS Ratio	3.67	3.46	3.39	4.92	5.15	7.65
PB Ratio	1.52	1.46	1.71	2.03	2.94	4.89
P/FCF Ratio	-	-	14.67	15.40	19.99	22.33
P/OCF Ratio	24.17	13.72	6.98	8.02	10.32	13.38
EV/Sales Ratio	9.26	8.03	6.84	8.74	10.87	12.37
EV/EBITDA Ratio	14.39	13.62	13.55	15.65	16.30	19.82
EV/EBIT Ratio	33.27	29.65	28.43	37.11	40.40	44.22
EV/FCF Ratio	-14.84	-	29.63	27.38	42.21	36.07
Debt / Equity Ratio	2.27	2.13	1.79	1.78	3.26	3.89
Debt / EBITDA Ratio	9.18	8.19	6.73	7.33	8.16	9.31
Debt / FCF Ratio	-	-	15.37	13.51	22.15	17.76
Quick Ratio	0.81	0.89	1.00	0.73	1.02	1.07
Current Ratio	1.08	0.96	1.08	0.78	1.17	1.17
Asset Turnover	0.12	0.12	0.16	0.14	0.13	0.13
Return on Equity (ROE)	1.02%	3.65%	5.68%	0.49%	2.36%	6.54%
Return on Assets (ROA)	1.67%	2.04%	2.34%	2.00%	2.10%	2.24%
Return on Capital (ROIC)	1.95%	2.41%	2.73%	2.28%	2.33%	2.45%
Return on Capital Employed (ROCE)	2.80%	3.50%	4.20%	3.40%	3.50%	3.60%
Earnings Yield	-0.33%	1.22%	2.25%	0.73%	0.48%	1.14%
Earnings Yield	-0.33%	1.22%	2.25%	0.73%	0.48%	1.14%
FCF Yield	-17.01%	-6.20%	6.82%	6.49%	5.00%	4.48%
Dividend Yield	2.23%	2.32%	2.02%	1.74%	2.04%	1.52%
Payout Ratio	-	188.89%	87.18%	226.67%	400.00%	120.00%
Buyback Yield / Dilution	0.04%	0.00%	-0.02%	-0.02%	-4.16%	-8.90%
Total Shareholder Return	2.27%	2.33%	2.00%	1.72%	-2.13%	-7.38%

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Utility template. Financial Sources.